MetLife (MET) Receives Extension to Resubmit Capital Plan

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 8/21/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY

6. AVGO
7. SPCX
8. BJ
9. OSIS
10. QQQ

June 19, 2012 8:25 AM EDT

Price: $94.32 +0.92%

Overall Analyst Rating:
SELL (= Flat)

Dividend Yield: 2.5%

According to a Form 8-K, MetLife (NYSE: MET) has received an extension to resubmit its capital plan. The company will now have until September 30th.

Corporate News, Fed

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!